Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ACADIA Pharmaceuticals In...

    NASDAQ: ACAD · Real-Time Price · USD
    21.36
    -0.41 (-1.88%)
    At close: Jun 05, 2025, 3:59 PM
    21.20
    -0.73%
    After-hours: Jun 05, 2025, 05:04 PM EDT

    ACADIA Pharmaceuticals Statistics

    Share Statistics

    ACADIA Pharmaceuticals has 167.36M shares outstanding. The number of shares has increased by 0.95% in one year.

    Shares Outstanding

    n/a
    		 167.36M

    Shares Change (YoY)

    n/a
    		 0.95%

    Shares Change (QoQ)

    n/a
    		 0.24%

    Owned by Institutions (%)

    n/a
    		 98.13%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 6

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 15.24M, so 9.11% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 15.24M

    Short % of Shares Out

    n/a
    		 9.11%

    Short % of Float

    n/a
    		 14.35%

    Short Ratio (days to cover)

    n/a
    		 6.93

    Valuation Ratios

    The PE ratio is 13.43 and the forward PE ratio is 25.28. ACADIA Pharmaceuticals's PEG ratio is -0.03.

    PE Ratio

    n/a
    		 13.43

    Forward PE

    n/a
    		 25.28

    PS Ratio

    n/a
    		 3.17

    Forward PS

    n/a
    		 2.2

    PB Ratio

    n/a
    		 4.15

    P/FCF Ratio

    n/a
    		 19.34

    PEG Ratio

    n/a
    		 -0.03
    Financial Ratio History

    Enterprise Valuation

    ACADIA Pharmaceuticals has an Enterprise Value (EV) of 2.77B.

    EV / Sales

    n/a
    		 2.9

    EV / EBITDA

    n/a
    		 27.69

    EV / EBIT

    n/a
    		 17.58

    EV / FCF

    n/a
    		 17.64

    Financial Position

    The company has a current ratio of 2.38, with a Debt / Equity ratio of 0.07.

    Current Ratio

    n/a
    		 2.38

    Quick Ratio

    n/a
    		 2.32

    Debt / Equity

    n/a
    		 0.07

    Debt / EBITDA

    n/a
    		 0.52

    Debt / FCF

    n/a
    		 0.33

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is 30.9% and Return on Invested Capital is 25.54%.

    Return on Equity

    n/a
    		 30.9%

    Return on Assets

    n/a
    		 19.07%

    Return on Invested Capital

    n/a
    		 25.54%

    Revenue Per Employee

    n/a
    		 $1,466,764.17

    Profits Per Employee

    n/a
    		 $346,785.6

    Employee Count

    n/a
    		 653

    Asset Turnover

    n/a
    		 0.81

    Inventory Turnover

    n/a
    		 3.73

    Taxes

    Income Tax

    n/a
    		 31.62M

    Effective Tax Rate

    n/a
    		 12.25%

    Stock Price Statistics

    The stock price has increased by 39.61% in the last 52 weeks. The beta is 0.65, so ACADIA Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.65

    52-Week Price Change

    n/a
    		 39.61%

    50-Day Moving Average

    n/a
    		 17.28

    200-Day Moving Average

    n/a
    		 17

    Relative Strength Index (RSI)

    n/a
    		 63.35

    Average Volume (20 Days)

    n/a
    		 2,077,352

    Income Statement

    In the last 12 months, ACADIA Pharmaceuticals had revenue of 957.8M and earned 226.45M in profits. Earnings per share was 1.37.

    Revenue

    n/a
    		 957.8M

    Gross Profit

    n/a
    		 875.96M

    Operating Income

    n/a
    		 230.79M

    Net Income

    n/a
    		 226.45M

    EBITDA

    n/a
    		 100.16M

    EBIT

    n/a
    		 84.28M

    Earnings Per Share (EPS)

    n/a
    		 1.37
    Full Income Statement

    Balance Sheet

    The company has 319.59M in cash and 51.99M in debt, giving a net cash position of 267.59M.

    Cash & Cash Equivalents

    n/a
    		 319.59M

    Total Debt

    n/a
    		 51.99M

    Net Cash

    n/a
    		 267.59M

    Retained Earnings

    n/a
    		 -2.2B

    Total Assets

    n/a
    		 1.13B

    Working Capital

    n/a
    		 568.41M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 157.72M and capital expenditures -523K, giving a free cash flow of 157.2M.

    Operating Cash Flow

    n/a
    		 157.72M

    Capital Expenditures

    n/a
    		 -523K

    Free Cash Flow

    n/a
    		 157.2M

    FCF Per Share

    n/a
    		 0.95
    Full Cash Flow Statement

    Margins

    Gross margin is 91.46%, with operating and profit margins of 24.1% and 23.64%.

    Gross Margin

    n/a
    		 91.46%

    Operating Margin

    n/a
    		 24.1%

    Pretax Margin

    n/a
    		 26.94%

    Profit Margin

    n/a
    		 23.64%

    EBITDA Margin

    n/a
    		 10.46%

    EBIT Margin

    n/a
    		 24.1%

    FCF Margin

    n/a
    		 16.41%

    Dividends & Yields

    ACAD does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 7.45%

    FCF Yield

    n/a
    		 5.17%
    Dividend Details

    Analyst Forecast

    The average price target for ACAD is $26, which is 21.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $26

    Price Target Difference

    n/a
    		 21.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 14
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 11.66

    Graham Upside

    n/a
    		 -45.41%

    Scores

    Altman Z-Score

    n/a
    		 5.06

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist